Table 2 Distribution of comorbidities among patient
From: Transoral laser microsurgery in early glottic carcinoma: an Egyptian experience
| Â | Â | Count | % |
|---|---|---|---|
Comorbidities | Free | 29 | 87.9% |
HCV | 1 | 3% | |
Diabetic | 1 | 3% | |
HTN | 2 | 6% |
From: Transoral laser microsurgery in early glottic carcinoma: an Egyptian experience
| Â | Â | Count | % |
|---|---|---|---|
Comorbidities | Free | 29 | 87.9% |
HCV | 1 | 3% | |
Diabetic | 1 | 3% | |
HTN | 2 | 6% |